Validation of preoperative BRAF V600E testing by ThyroSCAN PanelChip in thyroid nodules
Open Access
- 1 May 2025
- journal article
- Published by Bioscientifica in Endocrine Connections
- Vol. 14 (5)
Abstract
Objectives: The high cost of preoperative molecular testing remains a significant barrier to their widespread clinical use. This prospective study aims to investigate the clinical applicability of the ThyroSCAN PanelChip, a qPCR-based method, for preoperative BRAF V600E testing in thyroid nodules. Materials and methods: Adult patients undergoing fine-needle aspiration cytology in outpatient settings between April 2023 and June 2024 were enrolled, and molecular testing was performed on aspiration samples. For patients who proceeded to thyroidectomy, postoperative histopathological findings were compared with preoperative cytology and molecular results. Immunohistochemical VE1 staining on pathology specimens served as the gold standard to validate accuracy. A best-estimate approach was also employed to expand the evaluation, including presumed BRAF V600E-negative cases, such as RAS-positive specimens and benign lesions. Results: Among 73 patients who underwent thyroidectomy and were included in the analysis, preoperative molecular testing identified BRAF mutations in 22 patients, detected the wild-type gene in 39 and classified 12 as inaccessible due to insufficient DNA extraction. For the 38 patients with both preoperative genetic results and VE1 staining, performance metrics were: positive predictive value = 95.5%, negative predictive value = 75.0%, accuracy = 86.8%, sensitivity = 84.0% and specificity = 92.3%. Under the best-estimate approach, metrics improved to positive predictive value = 95.5%, negative predictive value = 89.5%, accuracy = 91.7%, sensitivity = 84.0% and specificity = 97.1%. Conclusion: These findings demonstrate that ThyroSCAN PanelChip effectively identifies BRAF V600E mutations in thyroid nodules using residual thyrocytes from fine-needle aspiration samples.Keywords
Funding Information
- National Science and Technology Council (110-2314-B-075-027-MY3, NSTC113-2314-B-075-007)
- Taipei Veterans General Hospital (V113C-166, V114C-177, V114C-225)
This publication has 25 references indexed in Scilit:
- An overview of technical considerations when using quantitative real-time PCR analysis of gene expression in human exercise researchPLOS ONE, 2018
- Thyroid Fine-Needle Aspiration in Taiwan: The History and Current PracticeJournal of Pathology and Translational Medicine, 2017
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Negative Fine‐Needle Aspiration in Patients with Goiter: Should We Doubt It?World Journal of Surgery, 2015
- False-negative fine-needle aspiration of thyroid nodules cannot be attributed to sampling error aloneThe American Journal of Surgery, 2012
- BRAFV600E Mutation Analysis in Fine-Needle Aspiration Cytology Specimens for Evaluation of Thyroid Nodule: A Large Series in aBRAFV600E-Prevalent PopulationThe Journal of Clinical Endocrinology & Metabolism, 2010
- Dual priming oligonucleotide–based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation–prevalent areaHead & Neck, 2009
- Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodulesCytojournal, 2006
- Fine Needle Aspiration of the Thyroid: A Cytohistologic Correlation and Study of Discrepant CasesThyroid®, 2004
- Management of a Solitary Thyroid NoduleNew England Journal of Medicine, 1993